Recombinant Human MMP-14/MT1-MMP (NS0-expressed) Protein, CF Summary
Details of Functionality
Measured by its ability to cleave a fluorogenic peptide substrate Mca-KPLGL-Dpa-AR-NH2 (Catalog # ES010). The specific activity is >350 pmol/min/μg, as measured under the described conditions.
Source
Mouse myeloma cell line, NS0-derived human MMP-14/MT1-MMP protein Ala21-Ser538, with an Arg108Pro mutation and a C-terminal 6-His tag
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Endotoxin Note
<1.0 EU per 1 μg of the protein by the LAL method.
Applications/Dilutions
Dilutions
Enzyme Activity
Theoretical MW
60 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
SDS-PAGE
60-65 kDa, reducing conditions
Publications
Read Publication using 918-MPN in the following applications:
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
6 months from date of receipt, -70 °C as supplied.
3 months, -70 °C under sterile conditions after opening.
Buffer
Supplied as a 0.2 μm filtered solution in Sodium Acetate, NaCl, CaCl2, Glycerol.
Purity
>80%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.
Assay Procedure
Assay Buffer: 50 mM Tris, 0.15 M NaCl, 10 mM CaCl2, 5 µM ZnCl2, 0.05% (w/v) Brij-35, pH 7.5
Recombinant Human MMP‑14/MT1‑MMP (rhMMP-14) (Catalog # 918-MPN)
Recombinant Human Trypsin 3 (rhTrypsin 3) (Catalog # 3714-SE)
AEBSF
(Catalog #
5175), 100 mM stock in deionized water
Substrate: MCA-Lys-Pro-Leu-Gly-Leu-DPA-Ala-Arg-NH2 (Catalog # ES010), 2 mM stock in DMSO
F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
Fluorescent Plate Reader (Model: SpectraMax Gemini EM by Molecular Devices) or equivalent
Activate rhMMP-14 at 100 µg/mL with 0.1 µg/mL rhTrypsin 3 in Assay Buffer.
Incubate at 37 °C for 1 hour.
Stop reaction with 1 mM AEBSF and incubate for 15 minutes at room temperature.
Dilute activated rhMMP-14 to 1 µg/mL in Assay Buffer.
Dilute Substrate to 80 µM in Assay Buffer.
In a plate, load 50 µL of 1 µg/mL rhMMP-14 to wells. For a Substrate Blank, load 50 µL of Assay Buffer.
Start the reaction by adding 50 µL of 80 µM Substrate to wells.
Read at excitation and emission wavelengths of 320 nm and 405 nm (top read), respectively, in kinetic mode for 5 minutes.
Calculate specific activity:
Specific Activity (pmol/min/µg) =
Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)
*Adjusted for Substrate Blank **Derived using calibration standard MCA-Pro-Leu-OH (Bachem, Catalog # M-1975).
Per Well:
rhMMP-14: 0.050 µg
Substrate: 40 µM
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for Recombinant Human MMP-14/MT1-MMP (NS0-expressed) Protein, CF
EC 3.4.24
EC 3.4.24.80
matrix metallopeptidase 14 (membrane-inserted)
matrix metalloproteinase 14 (membrane-inserted)
matrix metalloproteinase-14
membrane type 1 metalloprotease
Membrane-type matrix metalloproteinase 1
Membrane-type-1 matrix metalloproteinase
MMP14
MMP-14
MMP-X1
MT1MMP
MT1-MMP
MT1-MMPMTMMP1
MT-MMP 1
MT-MMP1
Background
The first identified member of membrane type (MT) MMPs, MMP-14, also known as MT1-MMP, plays an important role in extracellular matrix (ECM) remodeling by being able to degrade type 1 collagen, activate pro-MMP-2 and process cell adhesion molecules such as CD44 and integrin alpha v (1). MMP‑14 is therefore a key enzyme in many physiological and pathological processes such as angiogenesis and tumor invasion (2). Structurally, MMP-14 consists of the following domains: a pro domain containing the furin cleavage site, a catalytic domain containing the zinc-binding site, a hinge region, four hemopexin-like domains, a transmembrane domain, and a cytoplasmic tail (3). Recombinant human (rh) MMP-14, consists of the pro domain, catalytic domain, hinge region and hemopexin-like domains. Because it lacks the transmembrane domain, rhMMP-14 is secreted and purified as a soluble protein. The pro domain was engineered to contain an Arg108Pro mutation, which prevents activation by furin cleavage. Activation of rhMMP-14 occurs by treatment with rhTrypsin 3 as described in the Activity Assay Protocol.
Seiki, M. (2003) Cancer Lett. 194:1.
Friedl, P. and K. Wolf (2008) Cancer Res. 68:7247.
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
=
÷
Review this Product
Be the first to review our Recombinant Human MMP-14/MT1-MMP (NS0-expressed) Protein, CF and receive a gift card or discount.